Carla Greenbaum

Type 1 Diabetes TrialNet Clinical Network Hub

National Institute of Diabetes and Digestive and Kidney Diseases · U01

Contact PI · $14.2M · Benaroya Research Inst at Virginia Mason

Type 1 Diabetes in Acute Pancreatitis Consortium – Pacific Northwest Clinical Center: Immune Pathogenesis of Post-Pancreatitis T1D

National Institute of Diabetes and Digestive and Kidney Diseases · U01

Contact PI · $1.1M · Benaroya Research Inst at Virginia Mason

Northwest Clinical Center for Type 1 Diabetes - TrialNet

National Institute of Diabetes and Digestive and Kidney Diseases · U01

Contact PI · $10.3M · Benaroya Research Inst at Virginia Mason

In Vivo Assessment of T Cell Kinetics in Individuals at Risk for Type 1 Diabetes

National Institute of Diabetes and Digestive and Kidney Diseases · DP3

Contact PI · $1.1M · Benaroya Research Inst at Virginia Mason

Early Markers of Disease and Response to Therapy

Principal investigator · Completed · Early phase 1

Sandra Lord, MD

Targeting Beta Cell Dysfunction With Verapamil in Longstanding T1D

Principal investigator · Completed · Early phase 1

Benaroya Research Institute

Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D

Principal investigator · Completed · Early phase 1

Carla Greenbaum, MD

Modulation of STAT3 Signaling With Siltuximab in Type 1 Diabetes

Principal investigator · Completed · Early phase 1

Carla Greenbaum, MD